Hemorrhoid. Hemorrhoids and perianal venous thrombosis
Conditions
Interventions
Intervention 1: Intervention group: In Javid Iqbal's study, the mean bleeding in the intervention group was reported as 23±1. Considering the type I error (a) of 5% and the power of the test (ß-1) of
Sponsors
Mazandaran University of Medical Sciences
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Inclusion criteria
Inclusion criteria: Patients over 18 years of age with first and second degree hemorrhoids who referred to Imam Khomeini Hospital in Sari in 1402 will be included in the study.
Exclusion criteria
Exclusion criteria: Pregnant patients will be excluded from the study. Patients with diabetes mellitus will be excluded from the study. Patients with acute cardiac problems will be excluded from the study. Patients with previous anorectal surgeries will be excluded from the study. Grade 3 and 4 hemorrhoids will be excluded from the study. Inflamed or thrombosed hemorrhoids will be excluded from the study. Patients sensitive to sclerosing agents will be excluded from the study. Patients with colorectal carcinoma will be excluded from the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| In the study of the effect of sclerotherapy with sodium tetradecyl sulfate in the treatment of hemorrhoids, the primary outcome can be a 50% score reduction in the first stage and a 60% score reduction in the second stage of the patient questionnaire on the Likert scale. Timepoint: In the study of the effect of sclerotherapy with sodium tetradecyl sulfate in the treatment of hemorrhoids, the time points for measuring bleeding can be at the beginning of the study, 7, 21 days, 1 month, and 3 months after the start of the injection. Method of measurement: In the study of the effect of sclerotherapy with sodium tetradecyl sulfate in the treatment of hemorrhoids, the outcome variable can be measured using a Likert scale. | — |
Secondary
| Measure | Time frame |
|---|---|
| In the study of the effect of sclerotherapy with sodium tetradecyl sulfate in the treatment of hemorrhoids, the primary outcome can be a 50% score reduction in the first stage and a 60% score reduction in the second stage of the patient questionnaire on the Likert scale. Timepoint: In the study of the effect of sclerotherapy with sodium tetradecyl sulfate in the treatment of hemorrhoids, the time points for measuring prolapse can be at the beginning of the study, 7, 21 days, 1 month, and 3 months after the start of the injection. Method of measurement: In the study of the effect of sclerotherapy with sodium tetradecyl sulfate in the treatment of hemorrhoids, the outcome variable can be measured using a Likert scale. | — |
Countries
Iran (Islamic Republic of)
Contacts
Public ContactDr. Mina Alvandipour
Mazandaran University of Medical Sciences
Outcome results
None listed